SALSA MLPA Probemix P089 TK2 detects copy number variations in the MPV17, DGUOK, SUCLG1, RRM2B, SUCLA2 and TK2 genes associated with mitochondrial DNA depletion syndromes.
Contents: 49 MLPA probes, including 8 probes for MPV17, 4 probes each for DGUOK and SUCLG1, 9 probes for RRM2B, 5 probes for SUCLA2 and 10 probes for TK2.
Tissue: human genomic DNA.
Application: research on mitochondrial DNA (mtDNA) depletion syndromes.
For research use only (RUO). Not for use in diagnostics.
The SALSA MLPA Probemix P089 TK2 is a research use only (RUO) assay for the detection of deletions or duplications in MPV17, DGUOK, SUCLG1, RRM2B, SUCLA2 and TK2 genes, which are associated with Mitochondrial DNA depletion syndromes.
Mitochondrial DNA (mtDNA) depletion syndromes are a clinically and genetically heterogeneous group of autosomal recessive disorders, characterized by a severe reduction in mtDNA content, which leads to decreased energy production in the affected tissues (El-Hattab and Scaglia 2013). The myopathic form, mtDNA depletion syndrome-2 (MTDPS2; OMIM # 609560) is associated with defects in the TK2 gene. This syndrome is characterized by muscle weakness with childhood onset, associated with depletion of mtDNA in skeletal muscle.
The encephalomyopathic form with methylmalonic aciduria, mtDNA depletion syndrome-9 (MTDPS9; OMIM # 245400) is caused by defects in the SUCLG1 gene, and it is characterized by hypotonia, muscle atrophy, feeding difficulties, lactic acidosis, and development delay, among other symptoms. Defects in the SUCLA2 gene causes mtDNA depletion syndrome-5 (MTDPS5; OMIM # 612073), which is difficult to distinguish from the MTDPS-9, being both associated with elevated methylmalonic aciduria.
A severe form with renal tubulopathy, mtDNA depletion syndrome-8A (MTDPS8A; OMIM # 612075) is linked to defects in the RRM2B gene. This syndrome is characterized by neonatal hypotonia, lactic acidosis, neurologic deterioration, and renal tubular involvement.
The hepatocerebral form, mtDNA depletion syndrome-3 (MTDPS3; OMIM # 251880) is linked to defects in the DGUOK gene, and it is characterized by progressive liver failure and neurological abnormalities with infancy onset, hypoglicemia, and increased lactate in body fluids. mtDNA depletion and decrease activity of the mtDNA-enconded respiratory chain complexes (I, II, IV and V) are present in the affected tissues. mtDNA depletion syndrome-6 (MTDPS6; OMIM # 256810), another hepatocerebral form, is caused by defects in the MPV17 gene. MTDPS6 is characterized by infantile onset of progressive liver failure, frequently leading to death in the first year of live, progressive neurologic involvement, including ataxia, hypotonia, dystonia and psychomotor regression is present in the infants that survive.
More information is available at: https://www.ncbi.nlm.nih.gov/books/NBK425223/;
https://www.omim.org/entry/609560 (TK2);
https://www.omim.org/entry/612073 (SUCLA2);
https://www.omim.org/entry/245400 (SUCLG1);
https://www.omim.org/entry/256810 (MPV17);
https://www.omim.org/entry/612075 (RRM2B);
https://www.omim.org/entry/251880 (DGUOK).
SALSA MLPA Probemix P089 TK2 is for research use only (RUO) in all territories.
A general SALSA MLPA Reagent Kit is required for MLPA experiments (to be ordered separately).
The prices above are list prices for direct orders from MRC Holland. Contact us for a quote that takes discounts and additional costs (such as shipping costs) into account. Different prices apply for orders through one of our sales partners; contact your local supplier for a quote.
Inclusion of a positive sample is usually not required, but can be useful for the analysis of your experiments. MRC Holland has very limited access to positive samples and cannot supply such samples. We recommend using positive samples from your own collection. Alternatively, you can use positive samples from an online biorepository, such as the Coriell Institute.
The commercially available positive samples below can be used with the current (B2) version of this product.